Business Context and Reporting Period
Company: Creative Medical Technology Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 18, 2017
Reporting Period: Event-based report for December 18, 2017.
Business Context: The Company is an emerging growth company incorporated in Nevada. The filing reports the initiation of patient treatments using the Company's patented Caverstem™ procedure by Dr. Alexander Gershman.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
The material change reported is the commencement of clinical patient treatments utilizing the Caverstem™ procedure. No financial changes versus a prior comparable period are disclosed in this document.
Guidance, Outlook, and Risks
- Outlook: The press release furnished as Exhibit 99.1 contains forward-looking statements based on information available as of December 18, 2017.
- Risks: Actual results may differ materially from anticipated results due to various factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2016, and subsequent SEC filings.
- Management Commentary: Management assumes no duty or obligation to update or revise forward-looking statements, though updates may be made via future reports or press releases.
Investor Verification Checklist
- Verify the details of the Caverstem™ procedure and the scope of treatments initiated by Dr. Alexander Gershman in the press release (Exhibit 99.1).
- Review the Company's Annual Report on Form 10-K for the year ended December 31, 2016, for risk factors and historical financial context.
- Confirm the Company's status as an emerging growth company and any associated reporting exemptions.
- Monitor future filings for updates on the clinical progress or financial impact of the Caverstem™ procedure.